However, a number of reports have identified two areas of interest where ABCG2 may be functionally relevant in regards to CSCs and therapeutic response: in castration-resistant prostate cancer, and in radiation resistant cancer cells. The gene discussed is ABCG2; the disease is prostate cancer.